As part of the Comalive project, we compared simultaneously the repetitive assessment of consciousness performed with a behavioural scale (CRS-R) and a vibrotactile-based BCI to detect command following on a group of sixteen DOC (Fig. 2, 3). We could observe that the first CRS-R lead to a considerable rate of misdiagnosis. Moreover, over a comparative assessment that lasted at least two months, the BCI detected covert command following before the behavioural scale in several cases.
Moreover, we implemented a BCI training protocol on a cohort of DOC patients and analysed the effects on the behavioural responsivity assessed by the CRS-R. This research showed that BCI training protocols could be safely applied to DOC patients. Moreover, at the end of the two-week study period, we observed an improvement in the CRS-R score in 5 out of 10 DOC patients.
Still, as preparatory studies on communication with CLIS and DOC patients, we analysed the capacity to give consent to treatment (CCT) of severely disabled patients. This study showed that most Amyotrophic Lateral Sclerosis (ALS) patients preserve CCT, which is affected by frontal dysfunction and educational level.
We also tested a prototype vibrotactile-based BCI system with 7 stimuli on healthy subjects and patients.
Moreover, we reviewed the literature on the BCI applications on the DOC and developed a “clinical friendly guide” for not healthcare experts. Finally, we have undertaken a meta-analysis of the published data on the BCI paradigms used for detecting command following in the UWS patients.
Dissemination activities included five papers, three international conferences, including the Federation of European Neuroscience Societies (FENS) Forum, three workshops, including the BCI & Neurotechnology Spring School 2021, and several internal meetings.